185 / 1851
Co-stimulatory molecules, treatments in development
Name
Treatment
CD28:CD80/86
TAB08
CD27:CD70
Varilumab
CD40:CD40L
CP870, 893, ChiLob7/4
OX40:OX40L
MEDI0562, 6469, 6383,
MOXR0916
GITR:GITRL
TRX518
GWN323
MEDI1873
INCAGN01876
CD137: CD137L
Urelumab, PF-05082566